多家药企三季报披露:中药巨头盈利韧性凸显,创新药企“出海”加速

动脉网
Nov 05, 2025

医药企业2025年第三季度报告密集披露,中药板块通过精细化管理和成本控制展现出强大盈利韧性,如云南白药、白云山和东阿阿胶等公司均实现收入与利润双增长。其中,云南白药前三季度营业收入306.54亿元,同比增长2.47%,净利润47.77亿元,同比增长10.41%;白云山前三季度营业收入616.06亿元,同比增长4.31%,净利润33.10亿元,同比增长4.78%;东阿阿胶前三季度营业收入47.66...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10